CA-074 methyl ester

Cysteine Protease InhibitorRx: ResearchCompound: Research

Also known as: CA-074 Me, CA-074 methyl ester, CA-074ME, CA074 methyl ester, L-3-trans-(Propylcarbamoyl)oxirane-2-carbonyl-L-isoleucyl-L-proline methyl ester

Educational Only — Not medical advice. Consult a qualified clinician before using any peptide.

Source CA-074 methyl ester at Peptiology

Save 10% with code PEPTI-BOSSRABBIT-10

Shop Now & Save 10% →

Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.

Summary

CA-074 methyl ester is a cell‑permeable pro‑drug of the selective cathepsin B inhibitor CA‑074, used primarily as a research tool to study cathepsin B‑dependent pathways.

Mechanism of Action

Irreversible covalent inhibition of cathepsin B via epoxysuccinyl warhead after intracellular ester hydrolysis

Routes of Administration

In Vitro (cell Culture Medium)IntraperitonealIntravenousOral (experimental)Subcutaneous

Goals & Uses

  • Cathepsin B inhibitionTarget ValidationHigh
  • Apoptosis and autophagy pathway researchCell Biology ResearchModerate
  • Anti‑inflammatory researchPreclinicalModerate
  • Cancer biology researchOncology ResearchModerate
  • Neuroprotection researchNeuroscience ResearchModerate
  • NLRP3 inflammasome suppressionInflammation ResearchModerate
  • Cathepsin B inhibition (in vitro/in vivo research)Research Tool / Enzyme InhibitionHigh

Contraindications

  • Human therapeutic useRegulatory/safetyHigh

Adverse Effects

  • Cytotoxicity at high concentrationsIn Vitro ToxicityUncommon
  • Off-target protease inhibitionPharmacologicalRare
  • Unknown toxicitySystemicUnknown

Drug Interactions

No drug interactions recorded yet.

Population Constraints

  • Not for human administrationGeneral PopulationAbsolute

Regulatory Status

  • European UnionUnapprovedNot authorized for clinical use
  • United StatesUnapprovedResearch chemical only
  • United KingdomUnapprovedResearch reagent only; not reviewed by MHRA.

Not approved for human therapeutic use; employed only in preclinical and in‑vitro studies.

Evidence & Sources

No sources recorded yet.

Frequently Asked Questions

What is CA-074 methyl ester?

CA-074 methyl ester is a cell‑permeable pro‑drug of the selective cathepsin B inhibitor CA‑074, used primarily as a research tool to study cathepsin B‑dependent pathways.

What is CA-074 methyl ester used for?

CA-074 methyl ester is educationally associated with: Cathepsin B inhibition, Apoptosis and autophagy pathway research, Anti‑inflammatory research, Cancer biology research, Neuroprotection research, NLRP3 inflammasome suppression, Cathepsin B inhibition (in vitro/in vivo research). Educational only — not medical advice.

How is CA-074 methyl ester administered?

Recorded routes of administration: In Vitro (cell Culture Medium), Intraperitoneal, Intravenous, Oral (experimental), Subcutaneous.

What are the potential side effects of CA-074 methyl ester?

Reported adverse effects include: Cytotoxicity at high concentrations, Off-target protease inhibition, Unknown toxicity. This list is not exhaustive — consult a qualified clinician.

Who should avoid CA-074 methyl ester?

Recorded contraindications: Human therapeutic use. Consult a qualified clinician before use.